{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:17:29Z","timestamp":1792761449079,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":2237,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.jacc.2007.02.049","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T19:36:50Z","timestamp":1181245010000},"page":"2231-2237","source":"Crossref","is-referenced-by-count":436,"title":["The Role of Coenzyme Q10 in Statin-Associated Myopathy"],"prefix":"10.1016","volume":"49","author":[{"given":"Leo","family":"Marcoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2007.02.049_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200202143460721","article-title":"Cerivastatin and reports of fatal rhabdomyolysis","volume":"346","author":"Staffa","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2007.02.049_bib2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2007.02.049_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","article-title":"Statin-associated myopathy with normal creatine kinase levels","volume":"137","author":"Phillips","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2007.02.049_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1358\/dot.2005.41.4.908565","article-title":"Statin-associated neuromyotoxicity","volume":"41","author":"Baker","year":"2005","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.jacc.2007.02.049_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"Paiva","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2007.02.049_bib6","first-page":"362","article-title":"Isolation of a quinone from beef heart mitochondria","volume":"1000","author":"Crane","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacc.2007.02.049_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/j.1552-4604.1993.tb03948.x","article-title":"Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study","volume":"33","author":"Ghirlanda","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2007.02.049_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.abb.2003.12.025","article-title":"Antioxidant and prooxidant properties of mitochondrial coenzyme Q","volume":"423","author":"James","year":"2004","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jacc.2007.02.049_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1005568132027","article-title":"Interactions between ascorbyl free radical and coenzyme Q at the plasma membrane","volume":"32","author":"Arroyo","year":"2000","journal-title":"J Bioenerg Biomembr"},{"issue":"Suppl","key":"10.1016\/j.jacc.2007.02.049_bib10","doi-asserted-by":"crossref","first-page":"s57","DOI":"10.1016\/0098-2997(94)90013-2","article-title":"Interactions between ubiquinones and vitamins in membranes and cells","volume":"15","author":"Constantinescu","year":"1994","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jacc.2007.02.049_bib11","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1073\/pnas.87.22.8928","article-title":"Lovastatin decreases coenzyme Q levels in rats","volume":"87","author":"Willis","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2007.02.049_bib12","doi-asserted-by":"crossref","first-page":"8931","DOI":"10.1073\/pnas.87.22.8931","article-title":"Lovastatin decreases coenzyme Q levels in humans","volume":"87","author":"Folkers","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2007.02.049_bib13","first-page":"324","article-title":"Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients","volume":"49","author":"Miyake","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jacc.2007.02.049_bib14","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1067\/mhj.2001.116762","article-title":"The effect of pravastatin and atorvastatin on coenzyme Q10","volume":"142","author":"Bleske","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2007.02.049_bib15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/jcp.46.11.1055","article-title":"Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin","volume":"46","author":"Watts","year":"1993","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jacc.2007.02.049_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0009-9236(95)90266-X","article-title":"Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans","volume":"57","author":"Laaksonen","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2007.02.049_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00194398","article-title":"Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors","volume":"46","author":"Laaksonen","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2007.02.049_bib18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0002-9149(97)89180-1","article-title":"The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle","volume":"77","author":"Laaksonen","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2007.02.049_bib19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archneur.61.6.889","article-title":"Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke","volume":"61","author":"Rundek","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jacc.2007.02.049_bib20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2165\/00002018-200629080-00007","article-title":"Effect of ezetimibe and\/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial","volume":"29","author":"Berthold","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacc.2007.02.049_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2125.1996.04178.x","article-title":"Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate\/pyruvate ratio","volume":"42","author":"De Pinieux","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2007.02.049_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0009-8981(97)06557-1","article-title":"The effect of simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia","volume":"263","author":"Human","year":"1997","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacc.2007.02.049_bib23","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0022-2275(20)41990-X","article-title":"Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia","volume":"32","author":"Elmberger","year":"1991","journal-title":"J Lipid Res"},{"issue":"Suppl","key":"10.1016\/j.jacc.2007.02.049_bib24","doi-asserted-by":"crossref","first-page":"s187","DOI":"10.1016\/0098-2997(94)90028-0","article-title":"Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors","volume":"15","author":"Bargossi","year":"1994","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jacc.2007.02.049_bib25","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0002-9149(97)00174-4","article-title":"Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia","volume":"79","author":"Davidson","year":"1997","journal-title":"Am J Cardiol"},{"issue":"Suppl","key":"10.1016\/j.jacc.2007.02.049_bib26","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/S0098-2997(97)00014-9","article-title":"Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors","volume":"18","author":"Mortensen","year":"1997","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jacc.2007.02.049_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005344-199903000-00018","article-title":"Effects of lipid-lowering drugs on left ventricular function and exercise tolerance in dyslipidemic coronary patients","volume":"33","author":"de Lorgeril","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2007.02.049_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.287.5.598","article-title":"Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial","volume":"287","author":"Jula","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2007.02.049_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/biof.5520090218","article-title":"Distribution of antioxidants among blood components and lipoproteins: significance of lipids\/CoQ10 ratio as a possible marker of increased risk for atherosclerosis","volume":"9","author":"Tomasetti","year":"1999","journal-title":"Biofactors"},{"key":"10.1016\/j.jacc.2007.02.049_bib30","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.amjcard.2004.07.121","article-title":"Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction","volume":"94","author":"Silver","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2007.02.049_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0005-2760(92)90081-6","article-title":"Effects of mevinolin treatment on tissue dolichol and ubiquinone levels in the rat","volume":"1165","author":"Low","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacc.2007.02.049_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF02576234","article-title":"Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits","volume":"193","author":"Fukami","year":"1993","journal-title":"Res Exp Med (Berl)"},{"key":"10.1016\/j.jacc.2007.02.049_bib33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-2275(20)37449-6","article-title":"Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin","volume":"38","author":"Morand","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacc.2007.02.049_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/taap.1998.8491","article-title":"Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study","volume":"152","author":"Nakahara","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jacc.2007.02.049_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2003.08.013","article-title":"Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats","volume":"194","author":"Schaefer","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jacc.2007.02.049_bib36","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archneur.62.11.1709","article-title":"Muscle coenzyme Q10 level in statin-related myopathy","volume":"62","author":"Lamperti","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jacc.2007.02.049_bib37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0304-4165(94)90123-6","article-title":"Influences of lovastatin administration on the respiratory burst of leukocytes and the phosphorylation potential of mitochondria in guinea pigs","volume":"1200","author":"Diebold","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacc.2007.02.049_bib38","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1476-5381.1995.tb16679.x","article-title":"Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischaemic dog hearts","volume":"116","author":"Satoh","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacc.2007.02.049_bib39","first-page":"923","article-title":"HMG CoA reductase inhibitor accelerates aging effect on diaphragm mitochondrial respiratory function in rats","volume":"46","author":"Sugiyama","year":"1998","journal-title":"Biochem Mol Biol Int"},{"key":"10.1016\/j.jacc.2007.02.049_bib40","first-page":"189","article-title":"Effect of simvastatin therapy on blood and tissue ATP levels and erythrocyte membrane lipid composition","volume":"199","author":"Caliskan","year":"2000","journal-title":"Res Exp Med (Berl)"},{"key":"10.1016\/j.jacc.2007.02.049_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.atherosclerosis.2004.06.014","article-title":"Statin myotoxicity is associated with changes in the cardiopulmonary function","volume":"177","author":"Phillips","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2007.02.049_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0021-9150(99)00352-4","article-title":"Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients","volume":"150","author":"Paolisso","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2007.02.049_bib43","first-page":"483","article-title":"Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer","volume":"2","author":"Thibault","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jacc.2007.02.049_bib44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1006481423298","article-title":"Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma","volume":"19","author":"Kim","year":"2001","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jacc.2007.02.049_bib45","first-page":"3A","article-title":"Coenzyme Q10 improves myopathic pain in statin treated patients","volume":"45","author":"Kelly","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2007.02.049_bib46","first-page":"II41","article-title":"Coenzyme Q10 does not improve simvastatin tolerability in dyslipidemic patients with prior statin-induced myalgia","volume":"114","author":"Young","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2007.02.049_bib47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0002-9343(93)90129-D","article-title":"Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome","volume":"94","author":"Chariot","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2007.02.049_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000101287","article-title":"Statins provoking MELAS syndrome","volume":"57","author":"Thomas","year":"2007","journal-title":"Eur Neurol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109707010546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109707010546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T18:31:28Z","timestamp":1628965888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109707010546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":48,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0735109707010546"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2007.02.049","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}